Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis

• Hauptverfasser: Ya Zhou (Verfasst von), Zhihao Yao (Verfasst von), Linjie Zhu (Verfasst von), Yong Tang (Verfasst von), Jie Chen (Verfasst von), Jianming Wu (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2021-02-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background: Dabigatran is a univalent low-molecular-weight direct thrombin inhibitor which was developed as an alternative to vitamin K antagonists (VKAs). However, the safety of dabigatran remains controversial so far. In this study, we aimed to compare the risk of bleeding, fatal adverse events, a...